{"name":"Benitec Biopharma, Inc.","slug":"benitec-biopharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":59000,"revenueGrowth":-42.2,"grossMargin":0,"rdSpend":18332000,"netIncome":-37917000,"cash":99592000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2021"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"BB-401","genericName":"BB-401","slug":"bb-401","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"BB-401","genericName":"BB-401","slug":"bb-401","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-03-10","type":"pipeline","source":"GlobeNewswire","summary":"Benitec Biopharma to Host Industry Forum Breakfast Event at - GlobeNewswire","headline":"Benitec Biopharma to Host Industry Forum Breakfast Event at","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-14","type":"pipeline","source":"simplywall.st","summary":"Hedge funds owners may consider drastic measures as Benitec Biopharma Inc.'s (NASDAQ:BNTC) recent US$60m drop adds to long-term losses - simplywall.st","headline":"Hedge funds owners may consider drastic measures as Benitec Biopharma Inc.'s (NASDAQ:BNTC) recent US$60m drop adds to lo","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi_AFBVV95cUxOVnk0ZUs4a3hURmFuU29WeDQ3SU5QcXY3MGptS1NYbTFuOHJaUlUycmpMNUFEUzk4SlJ6OENmQzB4REU1czdjc3p4RHN5U1dHR18zaUZiT05BS3BhVkJBVnpqVmMzRzRoNzJOQ2pNRHF4TXJtaFhLUVVmRmlPUW5MU1E1M2lGRU0zNkUtT0NJZ1JQMjVSRFRFYnlweS1NTk1pLVZOcEYzM0FBSG9MN2lYaEwtSWphb3ZoaVFqYlIyR0NPSkVvZURlM1ZqOGhjV3JhU0IyVTVES3F3dEtlZDAwRk42S2dJMGw0dFhVbUVjWTNLenNzRmt4SVhrWTc?oc=5","date":"2026-02-12","type":"earnings","source":"GlobeNewswire","summary":"Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update - GlobeNewswire","headline":"Benitec Biopharma Releases Second Quarter 2026 Financial Results and Provides Operational Update","sentiment":"neutral"},{"date":"2026-02-12","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"date":"2026-02-12","type":"earnings","source":"SEC EDGAR","summary":"10-Q filed with SEC: 10-Q","headline":"Quarterly Report (10-Q) Filed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZ0FVX3lxTE5vWHhveFE0WEtXa1lucFR4YTEtYmJxQ1Jqc0lQRk1RWktSZEZ0eWdSUDFxSkZMcnVVS3gzUkpXQkU4cjRzWXhyTk9FZ3VtM0FFd2lNUFAtTkxBN2R4WFRIZHVmOEdFMzQ?oc=5","date":"2026-01-08","type":"pipeline","source":"Market.us","summary":"Intravenous Pegloticase Market Size, Share | CAGR of 13.8% - Market.us","headline":"Intravenous Pegloticase Market Size, Share | CAGR of 13.8%","sentiment":"neutral"},{"date":"2025-12-02","type":"regulatory","source":"SEC EDGAR","summary":"8-K filed with SEC: 8-K","headline":"SEC 8-K: 8-K","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxOUFlFUDBrN0o5dWFiUUY3SWpLZE12U1lDTnFfbmJjY0RzeXRDZmt5dWxDTjdtbnZDV3FSbGlSTUlib1NmNkRmVU5HdlU0b1hYT1dqYWN0SHFjcmFtZGJjRy1hRkVlLXB3NWVoWnh6UGdQQUlCdTQ5VlA0UHR1SEJIYnhmMUx6SWx2YU43d0I0Y0dxaTFMUWNjNWR1Snc?oc=5","date":"2024-09-30","type":"pipeline","source":"Yahoo Finance","summary":"Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc - Yahoo Finance","headline":"Suvretta Capital Management's Strategic Acquisition in Benitec Biopharma Inc","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxPZlphLU5lcmxXXzhTbzc2Q1dKcjBCWDlHeUU0RTllZ0pKWVN4OUFhSlVGX2I5SWZVMFc2R0FkTXVjRlY1aHNiRGU2amk5RFRueFAzVHJXYVNyTWNTaEcxeFNramV1U1E5NnI5V0RteEVDaDJyTzJSSno4dm5KbHcyVHdGYWlkQQ?oc=5","date":"2024-09-18","type":"pipeline","source":"grandviewresearch.com","summary":"Europe Rnai Technology Market Size & Outlook, 2025-2033 - grandviewresearch.com","headline":"Europe Rnai Technology Market Size & Outlook, 2025-2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMifkFVX3lxTE54SWpId3VkZFpLNklmR25qZU5CQ1lRVWhyZWNEOEt6SmRmXzMzdWhYejJrS0owVzlqVE5qZllaTlNmNHJSbHNQQjBhLVVmUGhpcFZmRzV2d2dickc2SVo3a0Y3SXhRNEYyRVlSN3FVOEVGWU50THBwaGVfeGdXQQ?oc=5","date":"2024-05-06","type":"pipeline","source":"Straits Research","summary":"Antisense and RNAi Therapeutics Market Size, Top Share | Industry Report, 2033 - Straits Research","headline":"Antisense and RNAi Therapeutics Market Size, Top Share | Industry Report, 2033","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZEFVX3lxTFBYLWllWkV5cjRsN2NnSUYyNl9TN0JEMnlBRTJmS19yVzRKWnZiMjlYcFFBMWhaQ1hUam03dDFnV24yY0hFS21YVFhGemQ0aDNGN2xmVU9vWjVVVFJ3cV9EUWtDYWw?oc=5","date":"2023-11-01","type":"pipeline","source":"Straits Research","summary":"Gene Therapy Market Size, Share & Growth Report by 2034 - Straits Research","headline":"Gene Therapy Market Size, Share & Growth Report by 2034","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7gFBVV95cUxPT1JUT3RiWWxGVE1jS3ZMRjMzS0V5YTlrVHV3Y0xsM3FJcFN6ZEU4VnA3ZXRsUUdZTHZUVlBGMVFoN2RjYUlveEw1YzRuZzFQNU1sY1ZfeTBSZFJyaG5lT0g2dTlYLVEtZ1VFQ0Zld0ZHX2lMSDNyeVFjcFdTUUVOVHJhZ2E5NXROQnU3dzBNbUZTT3A1WlFVMXR3bkFOenNhWURLUThVd3BWQ1dmVHdiRnZKZnZqM2ZvNldCZWxoWTlmVDJpMUdPeUVKWnA1QTBGQ2RVSjlyN3FsMXFxMGIycmpwQTczaU1QYVNSdEF3?oc=5","date":"2020-09-23","type":"earnings","source":"PR Newswire","summary":"Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results - PR Newswire","headline":"Benitec Biopharma Provides Operational Update and Releases its 2020 Fiscal Year-End Financial Results","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiZkFVX3lxTFBDTG1ST3dQakNkbjU0azh1OGRqcDFweHVDZG1CbDJrdEpicEhBbTVrYlBPcUxmY2ZORHZEZlIxeXVQbUEySnJQc25lLWhqcHg3YmRZMXVoekZtclFJRnZTa1EwRUN6Zw?oc=5","date":"2018-03-13","type":"pipeline","source":"Yahoo Finance UK","summary":"Benitec Biopharma Inc. (BNTC) valuation measures and financial statistics - Yahoo Finance UK","headline":"Benitec Biopharma Inc. (BNTC) valuation measures and financial statistics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMidEFVX3lxTFBhcG4zaV9oc29PckhKOHQzTGtSQk1XbWd5Ym5GYWlIYlFxbFROaC1SVjlQWWJKSGVkWFBPYnAwSEFFSk5ud0ZrSzI2YXZESXRwUlhzSFdQUm5TYnBvQzg1bzVRcjlvT1pjQjQwd0VsWXU3QmZm?oc=5","date":"2018-02-12","type":"pipeline","source":"Allied Market Research","summary":"RNA Based Therapeutics Market Size, Share | Report, 2030 - Allied Market Research","headline":"RNA Based Therapeutics Market Size, Share | Report, 2030","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":59000,"revenuePeriod":"2021-06-30","revenueHistory":[{"value":59000,"period":"2021-06-30"},{"value":102000,"period":"2020-06-30"},{"value":102000,"period":"2020-06-30"},{"value":12199000,"period":"2019-06-30"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":18332000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-37917000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":null,"cashHistory":[],"totalAssets":99592000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}